Zaorsky NG - Search Results

1

A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).

Valle LF, Lehrer EJ, Markovic D, Elashoff D, Levin-Epstein R, Karnes RJ, Reiter RE, Rettig M, Calais J, Nickols NG, Dess RT, Spratt DE, Steinberg ML, Nguyen PL, Davis BJ, Zaorsky NG, Kishan AU. Valle LF, et al. Among authors: zaorsky ng. Eur Urol. 2021 Sep;80(3):280-292. doi: 10.1016/j.eururo.2020.11.010. Epub 2020 Dec 11. Eur Urol. 2021. PMID: 33309278 Free PMC article. Review.

2

Systematic review of hypofractionated radiation therapy for prostate cancer.

Zaorsky NG, Ohri N, Showalter TN, Dicker AP, Den RB. Zaorsky NG, et al. Cancer Treat Rev. 2013 Nov;39(7):728-36. doi: 10.1016/j.ctrv.2013.01.008. Epub 2013 Mar 1. Cancer Treat Rev. 2013. PMID: 23453861 Free PMC article. Review.

3

The dilemma of a rising prostate-specific antigen level after local therapy: what are our options?

Zaorsky NG, Raj GV, Trabulsi EJ, Lin J, Den RB. Zaorsky NG, et al. Semin Oncol. 2013 Jun;40(3):322-36. doi: 10.1053/j.seminoncol.2013.04.011. Semin Oncol. 2013. PMID: 23806497 Review.

4

Evolution of advanced technologies in prostate cancer radiotherapy.

Zaorsky NG, Harrison AS, Trabulsi EJ, Gomella LG, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Zaorsky NG, et al. Nat Rev Urol. 2013 Oct;10(10):565-79. doi: 10.1038/nrurol.2013.185. Epub 2013 Sep 10. Nat Rev Urol. 2013. PMID: 24018567 Review.

5

Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer.

Zaorsky NG, Den RB, Doyle LA, Dicker AP, Hurwitz MD. Zaorsky NG, et al. Expert Rev Med Devices. 2013 Nov;10(6):751-63. doi: 10.1586/17434440.2013.841347. Expert Rev Med Devices. 2013. PMID: 24195459 Review.

6

High dose rate brachytherapy boost for prostate cancer: a systematic review.

Zaorsky NG, Doyle LA, Yamoah K, Andrel JA, Trabulsi EJ, Hurwitz MD, Dicker AP, Den RB. Zaorsky NG, et al. Cancer Treat Rev. 2014 Apr;40(3):414-25. doi: 10.1016/j.ctrv.2013.10.006. Epub 2013 Oct 26. Cancer Treat Rev. 2014. PMID: 24231548 Review.

7

A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.

Zaorsky NG, Yamoah K, Thakur ML, Trabulsi EJ, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Zaorsky NG, et al. Future Oncol. 2014 Feb;10(3):457-74. doi: 10.2217/fon.13.196. Future Oncol. 2014. PMID: 24559451 Free PMC article. Review.

8

Is robotic arm stereotactic body radiation therapy “virtual high dose ratebrachytherapy” for prostate cancer? An analysis of comparative effectiveness using published data [corrected].

Zaorsky NG, Hurwitz MD, Dicker AP, Showalter TN, Den RB. Zaorsky NG, et al. Expert Rev Med Devices. 2015 May;12(3):317-27. doi: 10.1586/17434440.2015.994606. Epub 2014 Dec 25. Expert Rev Med Devices. 2015. PMID: 25540018 Review.

9

What is the ideal radiotherapy dose to treat prostate cancer? A meta-analysis of biologically equivalent dose escalation.

Zaorsky NG, Palmer JD, Hurwitz MD, Keith SW, Dicker AP, Den RB. Zaorsky NG, et al. Radiother Oncol. 2015 Jun;115(3):295-300. doi: 10.1016/j.radonc.2015.05.011. Epub 2015 May 28. Radiother Oncol. 2015. PMID: 26028229 Review.

10

Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities.

Zaorsky NG, Keith SW, Shaikh T, Nguyen PL, Horwitz EM, Dicker AP, Den RB. Zaorsky NG, et al. Am J Clin Oncol. 2018 Apr;41(4):409-415. doi: 10.1097/COC.0000000000000285. Am J Clin Oncol. 2018. PMID: 27014930 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page